Shockwave Medical Stock News

Global Post-Market Study Will Assess Long-Term Benefit of Peripheral IVL on the Most Challenging Calcified Lesions, Including Patients with Critical Limb Ischemia Global Post-Market Study Will Assess Long-Term Benefit of Peripheral IVL on the Most Challenging Calcified Lesions, Including Patients with Critical Limb Ischemia

SANTA CLARA, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascul

SANTA CLARA, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the company will be participating in the Piper Sandler 33rd Annual Virtual Healthcare Conference, scheduled to be held from November 29 to December 2, 2021.

Zacks Investment Research downgraded shares of ShockWave Medical (NASDAQ:SWAV) from a hold rating to a sell rating in a research note issued to investors on Thursday morning, Zacks.com reports. According to Zacks, “ShockWave Medical, Inc. is a medical device company. It is focused on developing and commercializing products for medical device treatment of atherosclerotic cardiovascular […]

Zacks Investment Research lowered shares of ShockWave Medical (NASDAQ:SWAV) from a hold rating to a sell rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, ShockWave Medical, Inc. is a medical device company. It is focused on developing and commercializing products for medical device treatment of atherosclerotic cardiovascular disease. []

Shockwave Medical's (SWAV) third-quarter results reflect robust revenue growth and expansion in gross margin.

ShockWave Medical's (SWAV) CEO Doug Godshall on Q3 2021 Results - Earnings Call Transcript

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 171.43% and 5.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

ShockWave Medical (NASDAQ:SWAV) reported its Q3 earnings results on Monday, November 8, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement.

ShockWave Medical (SWAV) has been struggling lately, but the selling pressure may be coming to an end soon.

Disrupt PAD III Observational Arm Confirms IVL Safely and Effectively Modifies Superficial and Deep Calcium in Complex Calcified Lesions Disrupt PAD III Observational Arm Confirms IVL Safely and Effec

ShockWave appears well poised to benefit from macroeconomic crosscurrents driving procedure volumes in its end-markets. The company has grown revenues substantially and is in an accelerated growth per

SANTA CLARA, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ca

Frank T Watkins, Director at Shockwave Medical (NASDAQ:SWAV), made a large insider sell on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exch